CoChat
Sign Up
Cited by 14

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Age reprogramming: Innovations and ethical considerations for prolonged longevity (Review)

Saliev, Timur, Singh, Prim·2025·Biomedical Reports
DOI 10.3892/br.2025.1974PMC PMC12035601
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3892/br.2025.1974

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • If powerful and costly interventions are accessible only to the wealthy, they could create a "longevity dividend", exacerbating existing social and health inequities.

    “If such powerful and costly interventions are accessible only to the wealthy, they could create a “longevity dividend”, exacerbating existing social and health inequities.”

    From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [138]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 75

  1. Ayalon, 2019, A systematic review of existing ageism scales, Ageing Res Rev, 54, 10.1016/j.arr.2019.100919 · DOI
  2. Feng, 2019, Global convergence: Aging and long-term care policy challenges in the developing world, J Aging Soc Policy, 31, 291, 10.1080/08959420.2019.1626205 · DOI
  3. Mohd Tohit, 2024, Gerontology in public health: A scoping review of current perspectives and interventions, Cureus, 16, 10.7759/cureus.65896 · DOI
  4. Wagner, 2019, The link between epigenetic clocks for aging and senescence, Front Genet, 10, 10.3389/fgene.2019.00303 · DOI
  5. Alibhai, 2024, Rejuvenation of the aging heart: Molecular determinants and applications, Can J Cardiol, 40, 1394, 10.1016/j.cjca.2024.03.004 · DOI
  6. Iordache, 2024, Genetic and epigenetic interactions involved in senescence of stem cells, Int J Mol Sci, 25, 10.3390/ijms25179708 · DOI
  7. Guarente, 2024, Human trials exploring anti-aging medicines, Cell Metab, 36, 354, 10.1016/j.cmet.2023.12.007 · DOI
  8. Olova, 2025, Epigenetic rejuvenation: A journey backwards towards an epigenomic ground state, Epigenomics, 17, 1, 10.1080/17501911.2024.2432851 · DOI
  9. Park, 2024, Genetic and epigenetic alterations in aging and rejuvenation of human, Mol Cells, 47, 10.1016/j.mocell.2024.100137 · DOI
  10. Chen, 2024, The occurrence and development of induced pluripotent stem cells, Front Genet, 15, 10.3389/fgene.2024.1389558 · DOI
  11. Yang, 2024, Application prospects of urine-derived stem cells in neurological and musculoskeletal diseases, World J Orthop, 15, 918, 10.5312/wjo.v15.i10.918 · DOI
  12. Jiang, 2024, Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy, Semin Cancer Biol, 101, 58, 10.1016/j.semcancer.2024.05.002 · DOI
  13. Ruetz, 2024, CRISPR-Cas9 screens reveal regulators of ageing in neural stem cells, Nature, 634, 1150, 10.1038/s41586-024-07972-2 · DOI
  14. Falah, 2024, CRISPR-Cas9 mediated d3GHR knockout in HEK293 cells: Revealing the longevity associated isoform stress resilience, Exp Gerontol, 196, 10.1016/j.exger.2024.112586 · DOI
  15. Somers, 2010, Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette, Stem Cells, 28, 1728, 10.1002/stem.495 · DOI · Paper page
  16. Carter, 2020, The iNs and outs of direct reprogramming to induced neurons, Front Genome Ed, 2, 10.3389/fgeed.2020.00007 · DOI
  17. Esteves, 2023, Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials, Mech Ageing Dev, 214, 10.1016/j.mad.2023.111854 · DOI
  18. Towns, 2017, The science and ethics of cell-based therapies for Parkinson's disease, Parkinsonism Relat Disord, 34, 1, 10.1016/j.parkreldis.2016.10.012 · DOI
  19. Qi, 2014, Nuclear reprogramming and induced pluripotent stem cells: A review for surgeons, ANZ J Surg, 84, E1, 10.1111/j.1445-2197.2012.06282.x · DOI
  20. Wu, 2023, Epigenetic regulation in metabolic diseases: Mechanisms and advances in clinical study, Signal Transduct Target Ther, 8, 10.1038/s41392-023-01333-7 · DOI
  21. Dai, 2024, Epigenetics-targeted drugs: Current paradigms and future challenges, Signal Transduct Target Ther, 9, 10.1038/s41392-024-02039-0 · DOI
  22. Generali, 2024, Purification technologies for induced pluripotent stem cell therapies, Nat Rev Bioeng, 2, 930, 10.1038/s44222-024-00220-2 · DOI
  23. Park, 2024, Inducing pluripotency in somatic cells: Historical perspective and recent advances, Int J Stem Cells, 17, 363, 10.15283/ijsc23148 · DOI
  24. Bruno, 2024, Epigenetic OCT4 regulatory network: Stochastic analysis of cellular reprogramming, NPJ Syst Biol Appl, 10, 10.1038/s41540-023-00326-0 · DOI
  25. Kaemena, 2023, B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors, Nat Commun, 14, 10.1038/s41467-023-36097-9 · DOI
  26. Xie, 2020, The H2B ubiquitin-protein ligase RNF40 is required for somatic cell reprogramming, Cell Death Dis, 11, 10.1038/s41419-020-2482-4 · DOI
  27. Müller, 2021, MPP8 is essential for sustaining self-renewal of ground-state pluripotent stem cells, Nat Commun, 12, 10.1038/s41467-021-23308-4 · DOI
  28. Srinivasan, 2022, Epigenetic mechanisms of Strip2 in differentiation of pluripotent stem cells, Cell Death Discov, 8, 10.1038/s41420-022-01237-5 · DOI
  29. Saliev, 2024, From bench to bedside: Translating cellular rejuvenation therapies into clinical applications, Cells, 13, 10.3390/cells13242052 · DOI
  30. Jing, 2023, Genome-wide CRISPR activation screening in senescent cells reveals SOX5 as a driver and therapeutic target of rejuvenation, Cell Stem Cell, 30, 1452, 10.1016/j.stem.2023.09.007 · DOI
  31. Khetpal, 2023, Innovations in skin and soft tissue aging-A systematic literature review and market analysis of therapeutics and associated outcomes, Aesthetic Plast Surg, 47, 1609, 10.1007/s00266-023-03322-1 · DOI
  32. Maroufi, 2020, CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy, Epigenomics, 12, 1845, 10.2217/epi-2020-0110 · DOI
  33. Fadul, 2023, CRISPR-based epigenome editing: Mechanisms and applications, Epigenomics, 15, 1137, 10.2217/epi-2023-0281 · DOI
  34. Oshimura, 2024, Rejuvenation of human mesenchymal stem cells using a nonintegrative and conditionally removable Sendai virus vector, Sci Rep, 14, 10.1038/s41598-024-74757-y · DOI
  35. Salehpour, 2024, Therapeutic potential of mesenchymal stem cell-derived exosomes and miRNAs in neuronal regeneration and rejuvenation in neurological disorders: A mini review, Front Cell Neurosci, 18, 10.3389/fncel.2024.1427525 · DOI
  36. Saad, 2024, Gene therapy for skin aging, Curr Gene Ther, 25, 2, 10.2174/0115665232286489240320051925 · DOI
  37. Wu, 2024, The role and prospects of mesenchymal stem cells in skin repair and regeneration, Biomedicines, 12, 10.3390/biomedicines12040743 · DOI
  38. Ruscu, 2024, Pharmacological and stem cell therapy of stroke in animal models: Do they accurately reflect the response of humans?, Exp Neurol, 376, 10.1016/j.expneurol.2024.114753 · DOI
  39. Li, 2022, Efficacy of stem cell therapy in animal models of intracerebral hemorrhage: An updated meta-analysis, Stem Cell Res Ther, 13, 10.1186/s13287-022-03158-7 · DOI
  40. Ribitsch, 2020, Large animal models in regenerative medicine and tissue engineering: To do or not to do, Front Bioeng Biotechnol, 8, 10.3389/fbioe.2020.00972 · DOI
  41. Zheng, 2024, Applications of exosomal miRNAs from mesenchymal stem cells as skin boosters, Biomolecules, 14, 10.3390/biom14040459 · DOI
  42. Chehelgerdi, 2023, Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation, Mol Cancer, 22, 10.1186/s12943-023-01865-0 · DOI
  43. Yücel, 2024, The long and winding road of reprogramming-induced rejuvenation, Nat Commun, 15, 10.1038/s41467-024-46020-5 · DOI
  44. Zhang, 2024, Stem cell and regenerative therapies for the treatment of osteoporotic vertebral compression fractures, Int J Mol Sci, 25, 10.3390/ijms25094979 · DOI
  45. Jothi, 2024, Strategies for modeling aging and age-related diseases, NPJ Aging, 10, 10.1038/s41514-024-00161-5 · DOI
  46. Dhanjal, 2024, Advances in genetic reprogramming: Prospects from developmental biology to regenerative medicine, Curr Med Chem, 31, 1646, 10.2174/0929867330666230503144619 · DOI
  47. Balducci, 2024, Senotherapy, cancer, and aging, J Geriatr Oncol, 15, 10.1016/j.jgo.2023.101671 · DOI
  48. Meltzer, 2024, Reprogramming chromosome ends by functional histone acetylation, Int J Mol Sci, 25, 10.3390/ijms25073898 · DOI
  49. Kim, 2023, Transcriptional activation of endogenous Oct4 via the CRISPR/dCas9 activator ameliorates Hutchinson-Gilford progeria syndrome in mice, Aging Cell, 22, 10.1111/acel.13825 · DOI
  50. Yang, 2022, Reprogramming neurons for regeneration: The fountain of youth, Prog Neurobiol, 214, 10.1016/j.pneurobio.2022.102284 · DOI
  51. Tabibzadeh, 2021, From genoprotection to rejuvenation, Front Biosci (Landmark Ed), 26, 97, 10.2741/4890 · DOI
  52. Alvarez-Kuglen, 2024, ImAge quantitates aging and rejuvenation, Nat Aging, 4, 1308, 10.1038/s43587-024-00685-1 · DOI
  53. Pereira, 2024, Epigenetic reprogramming as a key to reverse ageing and increase longevity, Ageing Res Rev, 95, 10.1016/j.arr.2024.102204 · DOI
  54. Suslo, 2023, The future of care and healthcare provision to communitydwelling disa-bled elderly people in an ageing society, Fam Med Prim Care Rev, 25, 102, 10.5114/fmpcr.2023.126025 · DOI
  55. Iijima, 2021, Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan, Geriatr Gerontol Int, 21, 601, 10.1111/ggi.14201 · DOI
  56. Ok, 2022, Insights into the anti-aging prevention and diagnostic medicine and healthcare, Diagnostics (Basel), 12, 10.3390/diagnostics12040819 · DOI
  57. Kim, 2021, Recent advances in gene therapy for cardiac tissue regeneration, Int J Mol Sci, 22, 10.3390/ijms22179206 · DOI
  58. Goya, 2018, Rejuvenation by cell reprogramming: A new horizon in gerontology, Stem Cell Res Ther, 9, 10.1186/s13287-018-1075-y · DOI
  59. Santa Cruz-Pavlovich, 2024, Beyond vision: An overview of regenerative medicine and its current applications in ophthalmological care, Cells, 13, 10.3390/cells13020179 · DOI
  60. Gacic, 2024, Comparison of knowledge about induced pluripotent stem cells in relation to gender among healthcare professionals and in the general population, Cureus, 16, 10.7759/cureus.66821 · DOI
  61. Smajdor, 2019, An alternative to sexual reproduction: Artificial gametes and their implications for society, Br Med Bull, 129, 5, 10.1093/bmb/ldz001 · DOI
  62. Mkrtchyan, 2020, ARDD 2020: From aging mechanisms to interventions, Aging (Albany NY), 12, 24484, 10.18632/aging.202454 · DOI
  63. Kabata, 2023, The human genome as the common heritage of humanity, Front Genet, 14, 10.3389/fgene.2023.1282515 · DOI
  64. Hoffmann, 2019, Ethics review framework and guidelines for social science research, Soc Sci Res Ethics Afr, 7, 229, 10.1007/978-3-030-15402-8_16 · DOI
  65. Madathil, 2024, Bioethical and human right considerations during COVID-19 pandemic period: Reflections of integrated oncology clinical services from India, Ind J Med Paediatr Oncol, 45, 481, 10.1055/s-0043-1774779 · DOI
  66. Pimenta, 2023, Contemplating the principles of the UNESCO declaration on bioethics and human rights: A bioaesthetic experience, Int J Ethics Educ, 8, 249, 10.1007/s40889-023-00176-8 · DOI
  67. Nikitchina, 2024, Targeting of CRISPR-Cas12a crRNAs into human mitochondria, Biochimie, 217, 74, 10.1016/j.biochi.2023.09.006 · DOI
  68. Lim, 2024, Mitochondrial genome editing: Strategies, challenges, and applications, BMB Rep, 57, 19, 10.5483/BMBRep.2023-0224 · DOI
  69. Gao, 2024, Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: A review, Cytotherapy, 26, 11, 10.1016/j.jcyt.2023.10.004 · DOI
  70. Tao, 2024, Subtype-specific neurons from patient iPSCs display distinct neuropathological features of Alzheimer's disease, Cell Regen, 13, 10.1186/s13619-024-00204-y · DOI
  71. Antón-Fernández, 2024, In vivo cyclic overexpression of Yamanaka factors restricted to neurons reverses age-associated phenotypes and enhances memory performance, Commun Biol, 7, 10.1038/s42003-024-06328-w · DOI
  72. Calabrò, 2024, Senotherapeutics to counteract senescent cells are prominent topics in the context of anti-ageing strategies, Int J Mol Sci, 25, 10.3390/ijms25031792 · DOI
  73. Kaur, 2024, Emerging roles of senolytics/senomorphics in HIV-related co-morbidities, Biochem Pharmacol, 228, 10.1016/j.bcp.2024.116179 · DOI
  74. McHugh, 2025, Senescence as a therapeutic target in cancer and age-related diseases, Nat Rev Drug Discov, 24, 57, 10.1038/s41573-024-01074-4 · DOI · Paper page
  75. Martel, 2024, Lifestyle interventions to delay senescence, Biomed J, 47, 10.1016/j.bj.2023.100676 · DOI

Cited by

Sorted by citations

Metadata

Authors
Saliev, T., & Singh, P.
Venue
Biomedical Reports
Publisher
Spandidos Publications
Published
2025-04-10
Volume
22
Issue
6
Pages
1-15
ISSN
  • 2049-9434
  • 2049-9442
DOI
10.3892/br.2025.1974
PMC
PMC12035601
Cited by
14
References
5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review